⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Xenon Xe 127 SCHEMBL29617516 | 1.00 | — | — | |
| Methane SCHEMBL23088734 | 0.00 | — | — | |
| Hydrogen Sulfide SCHEMBL23805181 | 0.00 | — | — | |
| SCHEMBL23528133 | 0.00 | — | — | |
| SCHEMBL23358113 | 0.00 | — | — | |
| SCHEMBL23462252 | 0.00 | — | — | |
| SCHEMBL25435013 | 0.00 | — | — | |
| SCHEMBL23462141 | 0.00 | — | — | |
| Potassium Ion SCHEMBL23462035 | 0.00 | CA4 (0.50) | — | |
| SCHEMBL23462036 | 0.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024050031-A2 | NOVEL CAMPTOTHECIN DERIVATVES AS ANTIBODY-DRUG CONJUGATES (ADC) PAYLOADS | BIONECURE THERAPEUTICS INC (US) | 2024-03-07 | — | — | WO | disclosed |
| EP-4255694-A1 | METHOD FOR REDUNDANT CONTROL POLICIES FOR SAFE OPERATION OF AN EXOSKELETON | Sarcos Corp. (US) | 2023-10-11 | — | — | EP | disclosed |
| WO-2023192329-A1 | SYSTEMS AND METHODS FOR THE TREATMENT OF CANCER USING ULTRASOUND | DUKE UNIVERSITY (US) | 2023-10-05 | — | — | WO | disclosed |
| WO-2023178047-A1 | SOCIAL MEDIA PROFILE IDENTIFICATION CONNECTED TO CRYPTOGRAPHIC TOKEN | Emoji ID, LLC (US) | 2023-09-21 | — | — | WO | disclosed |
| WO-2022185311-A1 | SYSTEMS AND METHODS FOR MONITORING FLUID OF A FLUID FACILITY HAVING AN INSPECTION SUBSYSTEM FOR INSPECTION OF LIGHT SOURCES USED IN THE MONITORING SYSTEM | MAYTRONICS LTD. (IL) | 2022-09-09 | — | — | WO | disclosed |
| WO-2022125464-A1 | METHOD FOR REDUNDANT CONTROL POLICIES FOR SAFE OPERATION OF AN EXOSKELETON | Sarcos Corp. (US) | 2022-06-16 | — | — | WO | disclosed |
| EP-3931331-A1 | AAV VECTOR-MEDIATED DELETION OF LARGE MUTATIONAL HOTSPOT FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | Duke University (US) | 2022-01-05 | — | — | EP | disclosed |
| WO-2021216987-A1 | MAGNETICALLY INTERCONNECTABLE BLOCK STRUCTURES AND METHODS FOR MAKING THE SAME | IDEA VAULT HOLDINGS INC (US) | 2021-10-28 | — | — | WO | disclosed |
| EP-3897612-A1 | TREATMENT OF BREAST CANCER USING COMBINATION THERAPIES COMPRISING AN AKT INHIBITOR, A TAXANE, AND A PD-L1 INHIBITOR | Genentech, Inc. (US) | 2021-10-27 | — | — | EP | disclosed |
| EP-3844651-A1 | SECURITY CONFIGURATION FOR MEMORY ADDRESS TRANSLATION FROM OBJECT SPECIFIC VIRTUAL ADDRESS SPACES TO A PHYSICAL ADDRESS SPACE | Micron Technology, Inc. (US) | 2021-07-07 | — | — | EP | disclosed |
| WO-2007146312-A2 | WETTABLE SILICONE HYDROGEL CONTACT LENSES AND RELATED COMPOSITIONS AND METHODS | COOPER VISION INTERNATIONAL HOLDING COMPANY, LP (BB) | 2007-12-21 | — | — | WO | disclosed |
| WO-2007139826-A2 | METHOD FOR ELEVATING PROLACTIN IN MAMMALS | CARA THERAPEUTICS, INC. (US) | 2007-12-06 | — | — | WO | disclosed |
| WO-2007095312-A2 | IMAGE RECONSTRUCTION FROM LIMITED OR INCOMPLETE DATA | UNIVERSITY OF CHICAGO (US) | 2007-08-23 | — | — | WO | disclosed |
| WO-2007084402-A2 | COMPUTER BASED SYSTEM FOR TRAINING WORKERS | SILVERTREE MEDIA (US) | 2007-07-26 | — | — | WO | disclosed |
| WO-2007075923-A2 | TREATMENT OF SYNUCLEINOPATHIES | LINK MEDICINE CORPORATION (US) | 2007-07-05 | — | — | WO | disclosed |
| WO-2007064993-A2 | BICYCLIC PROTEIN KINASE INHIBITORS | OSI PHARMACEUTICALS, INC. (US) | 2007-06-07 | — | — | WO | disclosed |
| EP-1643836-A4 | ARYLMETHYL TRIAZOLO AND IMIDAZOPYRAZINES AS C-MET INHIBITORS | SUGEN INC (US) | 2006-12-06 | — | — | EP | disclosed |
| EP-1643836-A1 | ARYLMETHYL TRIAZOLO AND IMIDAZOPYRAZINES AS C-MET INHIBITORS | Sugen, Inc. (US) | 2006-04-12 | — | — | EP | disclosed |
| WO-2005004607-A1 | ARYLMETHYL TRIAZOLO AND IMIDAZOPYRAZINES AS C-MET INHIBITORS | SUGEN, INC. (US) | 2005-01-20 | — | — | WO | disclosed |
| EP-1123412-B1 | METHOD FOR MONITORING PROTEASOME INHIBITOR DRUG ACTION | MILLENNIUM PHARM INC (US) | 2004-10-06 | — | — | EP | disclosed |